Pathologic Complete Response and Individual Patient Prognosis After Neoadjuvant Chemotherapy Plus Anti-Human Epidermal Growth Factor Receptor 2 Therapy of Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer

  1. van Mackelenbergh, M.T.
  2. Loibl, S.
  3. Untch, M.
  4. Buyse, M.
  5. Geyer, C.E.
  6. Gianni, L.
  7. Schneeweiss, A.
  8. Conte, P.
  9. Piccart, M.
  10. Bonnefoi, H.
  11. Jackisch, C.
  12. Nekljudova, V.
  13. Tang, G.
  14. Valagussa, P.
  15. Neate, C.
  16. Gelber, R.
  17. Poncet, C.
  18. Squifflet, P.
  19. Saad, E.D.
  20. Heinzmann, D.
  21. Denkert, C.
  22. Rastogi, P.
  23. Cortes, J.
  24. Guarneri, V.
  25. de Azambuja, E.
  26. Cameron, D.
  27. Ismael, G.
  28. Wolmark, N.
  29. Cortazar, P.
  30. Erakutsi egile guztiak +
Aldizkaria:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology

ISSN: 1527-7755

Argitalpen urtea: 2023

Alea: 41

Zenbakia: 16

Orrialdeak: 2998-3008

Mota: Artikulua

DOI: 10.1200/JCO.22.02241 GOOGLE SCHOLAR